Lonnie Moulder, Zenas BioPharma founder and executive chair
November 7, 2022 04:00 PM ESTUpdated November 8, 10:04 AM
Deals

Lon­nie Moul­der’s new biotech play grabs $118M, steer­ing in­to PhI­II and more deals

John Carroll

Editor & Founder

Se­r­i­al biotech en­tre­pre­neur Lon­nie Moul­der has scored some big wins along the way, most no­tably the $9 bil­lion he racked up sell­ing MGI and Tesaro …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times